Cellebrite narrows FY25 revenue view to $470M-$475M from $465M-$475M

Consensus $469.38M. Raises FY25 adjusted EBITDA view to $124M-$127M from $118M-$123M. David Barter, Cellebrite’s (CLBT) CFO, commented, “Strong demand from customers within our U.S. state and local, and Latin America segments helped drive 21% growth in total subscription-based revenue. Our updated 2025 targets underpin our expectation for a free cash flow margin of approximately 30% for the full year. As we advance our 2026 planning activities, we are increasingly excited about the opportunity we see to drive durable top-line growth, drive incremental gains in profitability and generate low 30% free cash flow margins as we build greater scale and expand our wallet share with existing customers worldwide.”